Global Liver Institute
Fatty Liver Disease News
GLOBAL LIVER INSTITUTE
Stay up-to-date with the latest in the fatty liver disease field and subscribe to our monthly newsletters today!
The Most Common Chronic Liver Disease in the World – Fatty Liver Disease News
Last month, the GLI team proudly attended AASLD’s The Liver Meeting™, starting with our 10th anniversary celebration, which brought together patient advocates, industry leaders, and liver community members to celebrate a decade of impactful work.
Screening for MASLD is Cost-Effective for Patients – Fatty Liver Disease News
In this issue, we explore recent findings that highlight the need for dietary changes, including the link between ultra-processed foods and metabolic disorders in children with obesity, as well as the benefits of increasing plain water intake can reduce mortality risk.
Emerging Evidence in Liver Health: GLP-1, Pollution, and More – Fatty Liver Disease News
Despite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies.
New Guidelines & Actions for Change – Fatty Liver Disease News
New Clinical Practice Guidelines for MASLD, developed jointly by EASL, EASD, and EASO, update the 2016 guidelines to reflect recent advancements.
Understanding the New EASL-EASD-EASO Guidelines on MASLD
Clinical practice guidelines are evidence-based recommendations developed through systematic review and consensus to help healthcare providers and patients make informed decisions about the most appropriate treatment options for specific health conditions.
Fatty Liver Disease Affects Millions, But the Future for Treatment Remains Brighter Than Ever – Fatty Liver Disease News
The recent FDA approval of resmetirom, which offers hope for those with moderate-to-advanced liver scarring, marks a breakthrough in treatment.